BTMD
biote Corp
1.20$
-5.4%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +4,247.5% | +6.0% | +34.9% | +56.4% | -20.5% | -47.7% | +9.6% | +98.6% | -46.2% | -48.4% | -130.1% | – | |
| – | +263.0% | -50.3% | +16.8% | -7.5% | +40.5% | -24.7% | +6.2% | +4.6% | -0.1% | +3.0% | -1.7% | – | |
| – | -11.0% | -11.7% | +61.1% | -21.0% | -16.0% | +12.8% | +2.8% | +10.2% | -8.8% | -20.0% | +112.1% | – | |
| – | – | – | – | +79.1% | +289.1% | -156.1% | – | – | -161.7% | – | -22.9% | – | |
| – | +107.4% | +5.0% | +170.2% | -30.7% | -45.3% | +50.9% | +11.0% | -61.9% | +56.1% | +8.4% | +49.9% | – | |
| – | – | -164.1% | -72.6% | -40.8% | -33.6% | +41.0% | +6.2% | -64.8% | +242.6% | -50.6% | +124.7% | – | |
| – | +10.6% | -92.5% | +4,863.9% | +2.0% | -97.9% | +688.6% | +27.8% | -99.1% | +1,625.0% | +193.5% | +0.0% | – | |
| – | – | -1,073.3% | -63.0% | -100.0% | – | – | – | – | -100.0% | – | +347.4% | – | |
| – | – | – | – | – | +640.3% | -86.5% | -0.1% | +0.0% | – | -145.5% | – | – | |
| – | -1.4% | +114.2% | +990.3% | -97.0% | +461.9% | -77.3% | +1,106.6% | -81.9% | +85.0% | +135.9% | – | – | |
| – | – | -143.6% | – | – | -90.5% | +111.1% | -1,037.2% | – | -146.5% | – | – | – | |
| – | – | +6.1% | +12.4% | +91.3% | -16.9% | -57.1% | +9.1% | +153.6% | -51.5% | -57.9% | -207.1% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.